Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2007-06-19
2007-06-19
Lankford, Leon B. (Department: 1651)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S094100, C424S093600, C424S094610
Reexamination Certificate
active
10720266
ABSTRACT:
A lozenge for the treatment ofStreptococcusGroup A infections of the mouth, throat, and nasal passage is disclosed which comprises a lytic enzyme composition specific forStreptococcusGroup A and a lozenge carrier for delivering the lytic enzyme.
REFERENCES:
patent: 2019789 (1935-11-01), Mahannah
patent: 2315260 (1943-03-01), Lancaster
patent: 2763931 (1956-09-01), McMillan
patent: 3465445 (1969-09-01), Fisher
patent: 3622677 (1971-11-01), Short et al.
patent: 3852424 (1974-12-01), Gaeumann et al.
patent: 3929994 (1975-12-01), Hirsch et al.
patent: 3983209 (1976-09-01), Schmitt
patent: 4062941 (1977-12-01), Davies
patent: 4115546 (1978-09-01), Vidra et al.
patent: 4116327 (1978-09-01), Eglinton et al.
patent: 4122158 (1978-10-01), Schmitt
patent: 4313734 (1982-02-01), Leuvering
patent: 4355022 (1982-10-01), Rabussay
patent: 4361537 (1982-11-01), Deutsch et al.
patent: 4369308 (1983-01-01), Trubiano
patent: 4459361 (1984-07-01), Gefter
patent: 4497900 (1985-02-01), Abram et al.
patent: 4521252 (1985-06-01), Miyake et al.
patent: 4552839 (1985-11-01), Gould et al.
patent: 4707543 (1987-11-01), Zollinger et al.
patent: 4713249 (1987-12-01), Schroder
patent: 4742981 (1988-05-01), Converse
patent: 4784948 (1988-11-01), Scott et al.
patent: 4812445 (1989-03-01), Eden et al.
patent: 4847199 (1989-07-01), Snyder et al.
patent: 4885163 (1989-12-01), Shaar et al.
patent: 4933185 (1990-06-01), Wheatley et al.
patent: 4948726 (1990-08-01), Longoria
patent: 4957686 (1990-09-01), Norris
patent: 5079174 (1992-01-01), Buck et al.
patent: 5108758 (1992-04-01), Allwood et al.
patent: 5120643 (1992-06-01), Ching et al.
patent: 5162226 (1992-11-01), Beachey et al.
patent: 5260292 (1993-11-01), Robinson et al.
patent: 5294369 (1994-03-01), Shigekawa et al.
patent: 5352588 (1994-10-01), Fischetti et al.
patent: 5360617 (1994-11-01), Gasson
patent: 5372931 (1994-12-01), Friedman et al.
patent: 5384265 (1995-01-01), Kidwell et al.
patent: 5393658 (1995-02-01), Olsen
patent: 5479732 (1996-01-01), Burtch et al.
patent: 5500350 (1996-03-01), Baker et al.
patent: 5514602 (1996-05-01), Brooks, Jr. et al.
patent: 5556944 (1996-09-01), Fischetti et al.
patent: 5571667 (1996-11-01), Chu et al.
patent: 5587288 (1996-12-01), Cheung et al.
patent: 5602040 (1997-02-01), May et al.
patent: 5604109 (1997-02-01), Fischetti et al.
patent: 5604110 (1997-02-01), Baker et al.
patent: 5605793 (1997-02-01), Stemmer
patent: 5616686 (1997-04-01), Fischetti et al.
patent: 5643767 (1997-07-01), Fischetti et al.
patent: 5688501 (1997-11-01), Merril et al.
patent: 5707822 (1998-01-01), Fischetti et al.
patent: 5723303 (1998-03-01), Fischetti et al.
patent: 5741487 (1998-04-01), Asai et al.
patent: 5760026 (1998-06-01), Blackburn et al.
patent: 5763251 (1998-06-01), Gasson
patent: 5786205 (1998-07-01), Fischetti et al.
patent: 5821088 (1998-10-01), Darzins et al.
patent: 5842314 (1998-12-01), Porter
patent: 5882631 (1999-03-01), Suga et al.
patent: 5910441 (1999-06-01), Rocha et al.
patent: 5968763 (1999-10-01), Fischetti et al.
patent: 5976792 (1999-11-01), Cheung et al.
patent: 5985271 (1999-11-01), Fischetti et al.
patent: 5985654 (1999-11-01), Fischetti et al.
patent: 5997862 (1999-12-01), Fischetti et al.
patent: 6017528 (2000-01-01), Fischetti et al.
patent: 6056954 (2000-05-01), Fischetti et al.
patent: 6056955 (2000-05-01), Fischetti et al.
patent: 6083684 (2000-07-01), Gasson
patent: 6113887 (2000-09-01), Mori et al.
patent: 6132970 (2000-10-01), Stemmer
patent: 6159688 (2000-12-01), Borchert et al.
patent: 6177554 (2001-01-01), Woo et al.
patent: 6187757 (2001-02-01), Clackson et al.
patent: 6190659 (2001-02-01), Pancholi et al.
patent: 6238661 (2001-05-01), Fischetti et al.
patent: 6248324 (2001-06-01), Fischetti et al.
patent: 6254866 (2001-07-01), Fischetti et al.
patent: 6264945 (2001-07-01), Fischetti et al.
patent: 6277399 (2001-08-01), Fischetti et al.
patent: 6326002 (2001-12-01), Fischetti et al.
patent: 6331405 (2001-12-01), Rambukkana et al.
patent: 6335012 (2002-01-01), Fischetti et al.
patent: 6355477 (2002-03-01), Fischetti et al.
patent: 6423299 (2002-07-01), Fischetti et al.
patent: 0293249 (1988-11-01), None
patent: 0359873 (1990-03-01), None
patent: 0510907 (1992-10-01), None
patent: 587541 (1994-03-01), None
patent: 0646646 (1995-04-01), None
patent: 2357246 (1978-02-01), None
patent: WO-9323544 (1993-11-01), None
patent: WO-9531562 (1995-11-01), None
patent: WO-9607329 (1996-03-01), None
patent: WO-9702351 (1997-01-01), None
patent: WO-9904809 (1999-02-01), None
patent: WO 03/024410 (2003-03-01), None
KH Nasibulini et al; RU-2103991; Composition for treating streptococcal diseases—comprises purified concentrate of streptococcal bacteriophage, solution for quinsosol, dry lanolin, albumin and vegetable oil; XP-002141110.
LD Demidova et al; RU2064299; Cattle mastitis therapeutic preparation—comprises lyso: amidase of specific lytic activity and mono- and di-basic sodium phosphate(s); XP-00214111.
Babenko et al. Enzymatic lysis of staphylococci in relation to their species and strain properties, 1990, Database Medline Online, US National Library of Medicine, Bethesda, MD, US, Database Accession No. 90297672 XP002170795, abstract only.
Bartell, et al., Origin of polysaccharide depolymerase associated with bacteriophage infection, Journal of Virology, Mar. 1969, pp. 290-296, vol. 3, No. 3.
Behnke, et al., Cloning and expression inEscherichia coli, Bacillus subtilis and Streptococcus sanguisof a gene for staphylokinase—a bacterial plasminogen activator, Mol Gen Genet, Dec. 1987, pp. 528-534, vol. 210.
Bessen, et al., Chemical characterization of binding properties of opacity-associated protein II fromNeisseria gonorrheae, Infection and Immunity, Jan. 1987, pp. 141-147, vol. 55, No. 1.
Biziulevichius, et al., In vivo studies on lysosubtilin: 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows, 1998, Database Biosis Online, Biosciences Information Service, Philadelphia, PA, US, Database Accession No. PREV199800492606, XP002183274, abstract only.
Boizet, et al., Cloning, expression and sequence analysis of an endolysin-encoding gene ofLactobacillus bulgaricusbacteriophage mv1, Gene, 2000, pp. 61-67, vol. 94.
Caldwell, et al., Purification and partial characterization of the major outer membrane protein ofChlamydia trachomatis, Infection and Immunity, Mar. 1981, pp. 1161-1176, vol. 31, No. 3.
Young et al. Phages will out: strategies of host cell lysis, Trends in Microbiology, vol. 8 No. 3, Mar. 2000, pp. 120-127.
Corbel, et al., Soluble antigens obtained from influenza virus by treatment with non-ionic detergent, J Hyg.,Camb., 1970, pp. 81-96, vol. 68.
Croux, et al., Interchange of functional domains switches enzymes specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme, Molecular Microbiology, 1993, pp. 1019-1025, vol. 9, No. 5.
Diaz, et al., Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes, Proc. Natl. Acad. Sci. USA, Oct. 1990, pp. 8125-8129, vol. 87.
Diaz, et al., Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits, Journal of Biological Chemistry, Mar. 25, 1991, pp. 5464-5471, vol. 266, No. 9.
Dixon, et al., Lysostaphin: an enzymatic approach to staphylococcal disease. III. Combined lysostaphin-methicillin therapy of established staphylococcal abcesses in mice, The Yale Journal of Biology and Medicine, Aug. 1968, pp. 62-68, vol. 41, No. 1.
Fischetti, et al., Size variation of the M protein in group A streptococci, Journal of Exp of Exp. Med., Jun. 1, 1985, pp. 1384-1401, vol. 161, No. 6.
Garcia, et al., Bacteriophages ofStreptociccus pneumoniae: A molecular approach, Microbial Drug Resistance, Summer 1997, pp. 165-176, vol. 3, No. 2.
Garcia, et al., Cloning, purification and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin, Journal of Virology, Aug. 1987, pp. 2573-2580, vol. 61, No. 8.
Garcia, et al., Modular organization of the lytic enzymes ofStreptococcus pneumoniaeand its bacteriophages, Gene, 1990, pp. 81-8
Fischetti Vincent
Loomis Lawrence
Grant Jonathan
Grant Patent Services
Kim Taeyoon
Lankford Leon B.
New Horizons Diagnostics Corp
LandOfFree
Throat lozenge for the treatment of Streptococcus Group A does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Throat lozenge for the treatment of Streptococcus Group A, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Throat lozenge for the treatment of Streptococcus Group A will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3807761